DNA methylation age of human tissues and cell types
Human, observationalGenome Biology
Summary
Horvath built a multi-tissue DNA methylation age predictor (the 353-CpG clock) from about 8,000 samples across 82 Illumina array datasets covering 51 healthy tissues and cell types, and made it freely available. The predictor gave near-zero age for embryonic and induced pluripotent stem cells, tracked cell passage number, produced a heritable age-acceleration measure, and worked on chimpanzee tissues. Applied to about 6,000 cancer samples from 32 datasets, it showed age acceleration in all 20 cancer types examined, with a reported average of 36 years, and acceleration was linked to somatic and TP53 mutation patterns and steroid receptor mutations in breast cancer.
Key points
- A multi-tissue epigenetic clock using 353 CpG sites was trained on about 8,000 samples from 82 Illumina methylation array datasets spanning 51 healthy tissues and cell types.
- The predictor is publicly available, making it directly reusable for ageing and cancer analyses.
- DNA methylation age was near zero in embryonic and induced pluripotent stem cells and correlated with cell passage number.
- Age acceleration was reported as highly heritable and the clock also applied to chimpanzee tissues.
- All 20 cancer types analysed showed significant age acceleration, with a reported average of 36 years across about 6,000 cancer samples.